""

about | Maps & Directions | contact | admissions | faculty | alumni & development | library | Tech Support Center | dean's office | Policies & Procedures

FAculty directory

Back to alphabetical index

 

 

Ron Schey, MD, FACGron schey, md, facg

 

Associate Professor, Medicine

Telephone: 215-707-7602

Email: ron.schey@tuhs.temple.edu

 

 

Department of Medicine, Section of Gastroenterology

 

 

 

Educational Background:

 

MD, Sackler Faculty of Medicine, Tel Aviv, Israel, 1991

 

Internship, Sapir Medical Center, Tel Aviv University, Kfar-Saba, Israel, 1993

 

Residency, Sapir Medical Center, Tel Aviv University, Kfar-Saba, Israel, 1997

 

Fellowship, Gastroenterology & Hepatology, Edith Wolfson Medical Center, Holon, Israel, 2000

 

Fellowship, Neurogastroenterology, VA Medical Center, University of Arizona, Tucson, Arizona, 2007

 

Return to top

 

 

clinical Interests:

 
  • Esophageal disorders - gastroesophageal reflux disease (GERD), Barrett's esophagus, motility disorders, non-cardiac chest pain, eosinophilic esophagitis
  • Gastroparesis
  • Pelvic floor disorders, constipation, incontinence

Return to top

 

 

board certifications:

 

  • Internal Medicine
  • Gastroenterology

Return to top

 

 

professional affiliations:

 
  • Israel Medical Association
  • American Gastroenterological Association
  • American College of Gastroenterology
  • American Neurogastroenterology & Motility Society

Return to top

 

 

PUBMED PUBLICATIONS :


Recent Medically Related Publications, Obtained from PubMed (Click on PubMed ID to view abstract)

24918010. Frederickson NW, Bayman L, Valestin J, Redd M, Lee YJ, Soubra M, Schey R, Lack of seasonal variation in the incidence of eosinophilic oesophagitis in adolescent and adult non-PPI-responsive oesophageal eosinophilia midwestern US populations. United European Gastroenterol J 2:2(69-76)2014 Apr

24798996. Spengler EK, Dunkelberg J, Schey R, Alcoholic Hepatitis: Current Management. Dig Dis Sci :()2014 May 6

24506238. Hasan Y, Go J, Hashmi SM, Valestin J, Schey R, Influence of everyday bolus consistencies in different body positions on high-resolution esophageal pressure topography (HREPT) parameters. Dis Esophagus :()2014 Feb 7

24382218. Lee YJ, Redd M, Bayman L, Frederickson N, Valestin J, Schey R, Comparison of clinical features in patients with eosinophilic esophagitis living in an urban and rural environment. Dis Esophagus :()2014 Jan 2

23855975. Haslem BD, Samuelson MI, Schey R, A case of eosinophilic esophagitis discovered with positron emission tomography imaging: a case report. J Med Case Rep 7:(187)2013 Jul 15

23001405. Redd M, Schey R, Eosinophilic esophagitis: current treatment. Dig Dis Sci 58:3(613-20)2013 Mar

22907620. Schey R, Cromwell J, Rao SS, Medical and surgical management of pelvic floor disorders affecting defecation. Am J Gastroenterol 107:11(1624-33; quiz p.1634)2012 Nov

24833931. Soubra M, Schey R, Lubiprostone for the treatment of adult women with irritable bowel syndrome with constipation. Clin Med Insights Gastroenterol 5:(23-30)2012

21780893. Schey R, Rao SS, The role of rifaximin therapy in patients with irritable bowel syndrome without constipation. Expert Rev Gastroenterol Hepatol 5:4(461-4)2011 Aug

21523369. Schey R, Rao SS, Lubiprostone for the treatment of adults with constipation and irritable bowel syndrome. Dig Dis Sci 56:6(1619-25)2011 Jun

18797407. Schey R, Shapiro M, Navarro-Rodriguez T, Fass SS, Han B, Wendel C, Fass R, Comparison of the different characteristics of sensed reflux events among different heartburn groups. J Clin Gastroenterol 43:8(699-704)2009 Sep

18054551. Schey R, Dickman R, Parthasarathy S, Quan SF, Wendel C, Merchant J, Powers J, Han B, van Handel D, Fass R, Sleep deprivation is hyperalgesic in patients with gastroesophageal reflux disease. Gastroenterology 133:6(1787-95)2007 Dec

21960837. Schey R, Villarreal A, Fass R, Noncardiac chest pain: current treatment. Gastroenterol Hepatol (N Y) 3:4(255-62)2007 Apr

17183948. Schey R, Leichtmann G, Pomeranz I, Novis B, Konikoff F, [ERCP for benign disease in the elderly: a good prognosis]. Harefuah 145:11(795-7, 863)2006 Nov

15078482. Bruck R, Schey R, Aeed H, Hochman A, Genina O, Pines M, A protective effect of pyrrolidine dithiocarbamate in a rat model of liver cirrhosis. Liver Int 24:2(169-76)2004 Apr

11867181. Bruck R, Aeed H, Schey R, Matas Z, Reifen R, Zaiger G, Hochman A, Avni Y, Pyrrolidine dithiocarbamate protects against thioacetamide-induced fulminant hepatic failure in rats. J Hepatol 36:3(370-7)2002 Mar

11573870. Schey R, Avni Y, Bruck R, Shirin H, History of drug-induced hepatitis and risk of amoxicillin/clavulanate-induced hepatotoxicity. Ann Pharmacother 35:9(1142-3)2001 Sep

Return to top